Treatment

REGN13335 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
This study is looking at a new experimental drug, REGN13335, for adults with Pulmonary Arterial Hypertension (PAH). Researchers want to see if it's safe and effective when taken with other PAH medicines.
For: Pulmonary Arterial Hypertension (PAH)
United States · Latvia · South Korea